MedWatch

GN Hearing to transform activities with new head of research and development

Günther Pausch has been appointed the new head of research and development at GN Hearing.

Photo: GN Store Nord / PR

On Tuesday morning, GN Hearing's 2021 financial guidance was downgraded considerably due to delivery delays of components for the development of products, which were meant to be launched in the second half of the year.

The company has also decided to reorganize its research and development activities to increase the quality and predictability of delivery times.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

"Real world" patient data documents the long-term effects of ALK vaccines

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers. 

Further reading

Related articles

Latest news

See all jobs